Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation

Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation

Membrane transporters play an important role in the absorption, distribution, metabolism, and excretion of xenobiotic substrates, as well as endogenous compounds. The evaluation of transporter-mediated drug-drug interactions (DDIs) is an important consideration during the drug development process an...

Full description

Bibliographic Details
Main Authors:	Yang Li, Zahra Talebi, Xihui Chen, Alex Sparreboom, Shuiying Hu
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Molecules
Subjects:	membrane transporters endogenous biomarkers drug-drug interactions drug development
Online Access:	https://www.mdpi.com/1420-3049/26/18/5500

Similar Items

A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities
by: Yang Li, et al.
Published: (2022-09-01)

Role of Drug Metabolic Enzymes and Transporters in Drug-Drug Interactions Between Antiretroviral and Antituberculosis Drugs
by: Md Masud Parvez, et al.
Published: (2018-04-01)

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
by: Matthias Gorecki, et al.
Published: (2020-12-01)

Editorial: Drug metabolism and transport: the Frontier of personalized medicine
by: Junmin Zhang, et al.
Published: (2023-07-01)

Advances in Pharmacokinetic Mechanisms of Transporter-Mediated Herb-Drug Interactions
by: Jie Li, et al.
Published: (2022-09-01)

Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters
by: Kexin Lin, et al.
Published: (2023-07-01)

β-Lactam Antibiotics—Drug-Drug Interaction Mediated by Organic Anion Transporters OAT1 and OAT3
by: I. A. Mazerkina, et al.
Published: (2020-09-01)

Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021
by: Kyeong-Ryoon Lee, et al.
Published: (2022-09-01)

Transport and Permeation Properties of Dapivirine: Understanding Potential Drug-Drug Interactions
by: Ruohui Zheng, et al.
Published: (2022-09-01)

Renal drug transporters and their significance in drug–drug interactions
by: Jia Yin, et al.
Published: (2016-09-01)

Differential Preincubation Effects of Nicardipine on OATP1B1- and OATP1B3-Mediated Transport in the Presence and Absence of Protein: Implications in Assessing OATP1B1- and OATP1B3-Mediated Drug–Drug Interactions
by: Ruhul Kayesh, et al.
Published: (2023-03-01)

Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors
by: Dominique A. Garrison, et al.
Published: (2020-09-01)

Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes
by: Yiting Yang, et al.
Published: (2020-09-01)

Comparative evaluation of recommendations for preclinical studies of transporter-mediated drug–drug interactions
by: V. A. Evteev, et al.
Published: (2023-12-01)

Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging
by: Louise Breuil, et al.
Published: (2022-08-01)

Metabolism, Transport and Drug–Drug Interactions of Silymarin
by: Ying Xie, et al.
Published: (2019-10-01)

Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
by: Johanna Weiss, et al.
Published: (2020-09-01)

Transporter-Mediated Drug Delivery
by: Gergely Gyimesi, et al.
Published: (2023-01-01)

Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B
by: Dominique A. Garrison, et al.
Published: (2022-10-01)

Mechanisms and the clinical relevance of complex drug–drug interactions
by: Roberts AG, et al.
Published: (2018-09-01)

Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters
by: Zachary Lee Johnson, et al.
Published: (2014-07-01)

Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro
by: Johanna Weiss, et al.
Published: (2014-12-01)

Drug-Drug Interactions at Organic Cation Transporter 1
by: Shiwei Zhou, et al.
Published: (2021-02-01)

Analytical techniques and methods for study of drug-lipid membrane interactions
by: Li Hewen, et al.
Published: (2017-11-01)

Evaluation of OCT2‐mediated drug–drug interactions between ulotaront and metformin in subjects with schizophrenia
by: Guangqing Xiao, et al.
Published: (2024-04-01)

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
by: Jörg König, et al.
Published: (2011-10-01)

Entecavir interacts with influx transporters hOAT1, hCNT2, hCNT3, but not with hOCT2: the potential for renal transporter-mediated cytotoxicity and drug-drug interactions
by: František eTrejtnar, et al.
Published: (2016-01-01)

Interaction of ALK Inhibitors with Polyspecific Organic Cation Transporters and the Impact of Substrate-Dependent Inhibition on the Prediction of Drug–Drug Interactions
by: Yik Pui Tsang, et al.
Published: (2023-09-01)

Transporter-mediated drug–drug interactions – Study design, data analysis, and implications for in vitro evaluations
by: Shujun Fu, et al.
Published: (2021-09-01)

Overview of Drug Transporters in Human Placenta
by: Michiko Yamashita, et al.
Published: (2021-12-01)

Role of drug transporters in drug development: a qualitative and quantitative approach
by: Sumit Basu, et al.
Published: (2017-06-01)

Metabolism and transporter based drug–drug interaction of tacrolimus with nine co-medicated injections
by: Qing Xu, et al.
Published: (2021-06-01)

Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters
by: Eun Jeong Park, et al.
Published: (2020-10-01)

Interactions of 172 plant extracts with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8): a study on herb-drug interactions
by: Hang Lu, et al.
Published: (2017-05-01)

Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers
by: Gabriel Kigen, et al.
Published: (2017-05-01)

Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug–Drug Interactions
by: Johanna Weiss, et al.
Published: (2016-02-01)

Data-driven prediction of adverse drug reactions induced by drug-drug interactions
by: Ruifeng Liu, et al.
Published: (2017-06-01)

Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity
by: Chen Ning, et al.
Published: (2021-09-01)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
by: Asiimwe IG, et al.
Published: (2022-11-01)

Study on the pathogenicity, immunogenicity, endogenous development and drug sensitivity of Eimeria kongi
by: Sufang Fang, et al.
Published: (2023-03-01)